Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Reducing the economic burden in management of Guillain-Barre syndrome using modified plasmapheresis.
Involvement of the optic nerve in mutated CSF1R-induced hereditary diffuse leukoencephalopathy with axonal spheroids.
Women's experiences of menopause in an online MS cohort: A case series.
Poster 373 Paradoxically Increased Rigidity After Intrathecal Baclofen Injection in a Patient with Multiple Sclerosis: A Case Report.
Progression of alpha-synuclein pathology in multiple system atrophy of the cerebellar type.
Cognitive Impairment in Multiple Sclerosis.
Proton-gated Ca(2+)-permeable TRP channels damage myelin in conditions mimicking ischaemia.
Isolated pure verbal amnesia as the disease onset of probable multiple sclerosis with a left forniceal black hole.
Enhancement of aptamer immobilization using egg shell-derived nano-sized spherical hydroxyapatite for thrombin detection in neuroclinic.
Grey matter atrophy is associated with disability increase in natalizumab-treated patients.
Determinants of non-adherence to disease-modifying therapies in multiple sclerosis: A cross-Canada prospective study.
Interleukin 17 alone is not a discriminant biomarker in early demyelinating spectrum disorders.
Transneuronal Degeneration of Thalamic Nuclei following Middle Cerebral Artery Occlusion in Rats.
Relationship of grey and white matter abnormalities with distance from the surface of the brain in multiple sclerosis.
Sensory information treatment during disturbed standing posture in chronic acquired demyelinating polyneuropathies (CADP).
Comment on Paraparetic Guillain-Barré syndrome: non-demyelinating reversible conduction failure restricted to the lower limbs.
Brain activation changes during locomotion in middle-aged to older adults with multiple sclerosis.
Multiple sclerosis.
High-dose erythropoietin in patients with progressive multiple sclerosis: A randomized, placebo-controlled, phase 2 trial.
Pivotal Role of Brain Derived Neurotrophic Factor Secreted by Mesenchymal Stem Cells in Severe Intraventricular Hemorrhage in the Newborn Rats.
Cognitive impairment in MS: rehabilitation approaches.
Lithium improves cell viability in psychosine-treated MO3.13 human oligodendrocyte cell line via autophagy activation.
Diagnostic Yield and Safety of Brain Biopsy for Suspected Primary Central Nervous System Angiitis.
Evaluation of AD-MSC (adipose-derived mesenchymal stem cells) as a vehicle for IFN-β delivery in experimental autoimmune encephalomyelitis.
Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO).
Pages
« first
‹ previous
…
821
822
823
824
825
826
827
828
829
…
next ›
last »